SauerR., BeckerH., HoyhenbergerW., RödelC., WittekindC., FietkauR., MartusP., TschmelitschJ., HagerE., HessC.F., KarstensJ.H., LierschT., SchmidbergerH., RaabR.; For the German Rectal Cancer Study
Group: Pre-operative versus post-operative chemoradiotherapy for
rectal cancer. New Engl J Med,
351: 1731–1740,
2004.
2.
BossetJ.F., ColletteL., CalaisG., MineurL., MaingonP.,
Radosevic-JelicL., DabanA., BardetE., BenyA., OllierJ.C.; EORTC Radiotherapy Group Trial
22921: Chemotherapy with pre-operative radiotherapy in rectal
cancer. N Engl J Med, 355:
1114–1123, 2006.
3.
GérardJ.P., ConroyT., BonnetainF., BouchéO., ChapetO.,
Clo-son-DejardinM.T., UntereinerM., LeducB., FrancoisE., MaurelJ., SeitzJ.F., BuecherB., MackiewiczR., DucreuxM., BedenneL.: Preoperative
radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4
rectal cancers: results of FFCD 9203. J Clin
Oncol, 24:
4620–4625, 2006.
4.
BujkoK., NowackiM.P.,
Nasierowska-GuttmejerA., MichalskiW., BebenekM., KryjM.: Long-term results of a
randomized trial comparing preoperative short-course radiotherapy with
preoperative conventionally fractionated chemoradiation for rectal
cancer. Br J Surg, 93:
1215–1223, 2006.
5.
PeetersK.C., MarijnenC.A., NagtegaalID, KranenbargE.K., PutterH., WiggersT., RuttenH., PahlmanL., GlimeliusB., LeerJ.W., van de
VeldeC.J.: Dutch Colorectal
Cancer Group The TME trial after a median follow-up of 6 years: increased
local control but no survival benefit in irradiated patients with resectable
rectal carcinoma. Ann Surg,
246: 693–701,
2007.
6.
BraendengenM., TveitK.M., BerglundA., BirkemeyerE., FrykholmG., PåhlmanL., WiigJ.N., ByströmP., BujkoK., GlimeliusB.: Randomized phase III
study comparing pre-operative radiotherapy with chemoradiotherapy in
nonresectable rectal cancer. J Clin Oncol,
26: 3687–3694,
2008.
7.
Sebag-MontefioreD., StephensR.J., SteeleR., MonsonJ., GrieveR., KhannaS., QuirkeP., CoutureJ., de MetzC., MyintA.S., BessellE., GriffithsG., ThompsonL.C., ParmarM.: Preoperative
radiotherapy versus selective postoperative chemoradiotherapy in patients
with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised
trial. Lancet, 373:
811–820, 2009.
8.
QuirkeP., WilliamsG.T., EctorsN., EnsariA., PiardF., NagtegaalI.: The future of the TNM
staging system in colorectal cancer: time for a debate?Lancet Oncol, 8:
651–657, 2007.
9.
BipatS., GlasA.S., SlorsFj, ZwindermanA.H., BossuytP.M., StokerJ.: Rectal cancer: local
staging and assessment of lymph node involvement with endoluminal US, CT and
MRI imaging: a meta-analysis. Radiology,
232: 773–783,
2004.
10.
MaruschF., KochA., SchmidtU., ZippelR., KuhnR., WolffS., ProssM., WierthA., GastingerI., LippertH.: Routine use of
transrectal ultrasound in rectal carcinoma: results of a prospective
multicenter study. Endoscopy,
34: 385–390,
2002.
11.
PtokH., MaruschF., MeyerF., WendlingP., WenischH.J., SendtW., MangerT., LippertH., GastingerI.: Feasibility and
accuracy of TRUS in the pretreatment staging for rectal carcinoma in general
practice. Eur J Surg Oncol,
32: 420–425,
2006.
12.
NesbakkenA., LovigT., LundeO.C., NygaardK.: Staging of rectal
carcinoma with transrectal ultrasonography. Scand J
Surg, 92: 125–129,
2003.
13.
Beets-TanR.G., BeetsG.L., VliegenR.F., KesselsA.G., Van BovenH., De BruineA., von
MeyenfeldtM.F., BaetenC.G., van
EngelshovenJ.M.: Accuracy of magnetic
resonance imaging in prediction of tumor-free resection margin in rectal
cancer surgery. Lancet,
357: 497–504,
2001.
KulinnaC., ScheidlerJ., StraussT., BonelH., HerrmannK., AustD., ReiserM.: Local staging of rectal
cancer: assessment with double-contrast multislice computed tomography and
transrectal ultrasound. J Comput Assist
Tomogr, 28: 123–130,
2004.
16.
GearhartS.L., FrassicaD., RosenR., ChotiM., SchulickR., WahlR.: Improved staging with
pretreatment positron emission tomography/computed.
Ann Surg Oncol, 13:
397–404, 2006.
17.
MERCURY Study Group:
Extramural depth of tumor invasion at thin-section MR in
patients with rectal cancer: results of the Mercury Study.
Radiology, 243:
132–139, 2007.
18.
LahayeM.J., EngelenS.M., NelemansP.J., BeetsG.L., van de
VeldeC.J., van
EngelshovenJ.M., Beets-TanR.G.: Imaging for
predicting the risk factors - the circumferential resection margin and nodal
disease - of local recurrence in rectal cancer: a
meta-analysis. Semin Ultrasound CT MR,
26: 259–268,
2005.
19.
VliegenR., DresenR., BeetsG.,
Daniels-GooszenA., KesselsA., van
EngelshovenJ., Beets-TanR.: The accuracy of
multi-detector row CT for the assessment of tumor invasion of the mesorectal
fascia in primary rectal fascia. Abdom
Imaging, 33:
604–610, 2008.
KohD.M., ChauI., TaitD., WotherspoonA., CunninghamD., BrownG.: Evaluating mesorectal
lymph nodes in rectal cancer before and after neoadjuvant.
Int J Radiat Oncol Biol Phys, 71:
456–461, 2008.
22.
BarbaroB., FiorucciC., TebalaC., ValentiniV., GambacortaM.A., VecchioF.M., RizzoG., CocoC., CrucittiA., RattoC., BonomoL.: Locally advanced rectal
cancer: MR imaging in prediction of response after preoperative chemotherapy
and radiation therapy. Radiology,
250: 730–739,
2009.
GuerrieriM., BaldarelliM., OrganettiL., Grillo
RuggeriF., MantelloG., BartolacciS., LezocheE.: Transanal endoscopic
microsurgery for the treatment of selected patients with distal rectal
cancer: 15 years experience. Surg Endosc,
22: 2030–2035,
2008.
25.
StamosM.J., MurrellZ.: Management of early
rectal T1 and T2 cancers. Clin Cancer Res,
13: 6885–6889s,
2007.
26.
WillettC.G.: Sphincter
preservation in rectal cancer. Local excision followed by postoperative
radiation therapy. Semin Radiat Oncol,
8: 24–29,
1998.
27.
RaduC., BerglundK., PåhlmanL., GlimeliusB.: Short-course
preoperative radiotherapy with delayed surgery in rectal cancer - A
retrospective study. Radiother Oncol,
87: 343–349,
2008.
28.
ValentiniV., Beets-TanR., BorrasJ.M., KrivokapiZ., LeerJ.W., PåhlmanL., RödelC., SchmollH.J., ScottN., VeldeC.V., VerfaillieC.: Evidence and research
in rectal cancer. Radiother Oncol,
87: 449–474,
2008.
29.
GundersonL.L., SargentD.J., TepperJ.E., WolmarkN., O'ConnellM.J., BegovicM., AllmerC., ColangeloL., SmalleyS.R., HallerD.G., MartensonJ.A., MayerR.J., RichT.A., AjaniJ.A., MacDonaldJ.S., WillettC.G., GoldbergR.M.: Impact of T and N
substage on survival and disease relapse in adjuvant rectal cancer: a pooled
analysis. Int J Radiat Oncol Biol Phys,
54: 386–396,
2002.
30.
PåhlmanL.: Optimal management of
rectal cancer - Is sphincter saving an important end-point?EJC Supplements, 65:
365–369, 2005.
31.
MunroA.J., BentleyA.: Adjuvant radiotherapy
in operable rectal cancer: a systematic review. Sem
Colon Rectal Surg, 13:
31–42, 2002.
32.
GlimeliusB., GronbergH., JarnhultJ., WallgrenA.,
Cavallin-StåhlE.: A systematic overview
of radiation therapy effects in rectal cancer. Acta
Oncol, 42: 476–492,
2003.
33.
PahlmanL., GlimeliusB.: Pre- or postoperative
radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized
multicenter trial. Ann Surg,
211: 187–195,
1990.
MannaertsG.H., RuttenH.J., MartijnH., HanssensP.E., WiggersT.: Comparison of
intraoperative radiation therapy-containing multimodality treatment with
historical treatment modalities for locally recurrent rectal
cancer. Dis Colon Rectum,
44: 1749–1758,
2001.
37.
RosenM., ChanL., BeartR.W.Jr.,
VukasinP., AnthoneG.: Follow-up of colorectal
cancer. A meta-analysis. Dis Colon Rectum,
41: 1116–1126,
1998.
38.
GenovesiD., CèfaroG.A., VinciguerraA., AugurioA., D'AlessandroM., BorzilloV., MarcheseR., Di NicolaM.: Retrospective long-term
results and prognostic factors of postoperative treatment for UICC stages II
and III rectal cancer. Tumori,
95: 675–682,
2009.
39.
Di FabioF., KollerM., NascimbeniR., TalaricoC., SalerniB.: Long-term outcome after
colorectal cancer resection. Patients’ self-reported quality of life, sexual
dysfunction and surgeons’ awareness of patients’ needs.
Tumori, 94:
30–35, 2008.
40.
GuillouP.J., QuirkeP., ThorpeH., WalkerJ., JayneD.G., SmithA.M., HeathR.M., BrownJ.M.: Short-term endpoints
of conventional versus laparoscopic-assisted surgery in patients with
colorectal cancer (MRC CLASICC trial): multicentre, randomized controlled
trial. Lancet, 365:
1718–1726, 2005.
41.
QuirkeP., SteeleR., MonsonJ., GrieveR., KhannaS., CoutureJ., O'CallaghanC., MyintA.S., BessellE., ThompsonL.C., ParmarM., StephensR.J.,
Sebag-MontefioreD.: Effect of the plane of
surgery achieved on local recurrence in patients with operable rectal
cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16
randomised clinical trial. Lancet,
373: 821–828,
2009.